These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22083193)

  • 1. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
    Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of palliative chemotherapy with S-1 for oral cancer patients].
    Koga M; Aoki M; Anegawa E; Tezuka M; Iwamoto O; Koga C; Kusukawa J
    Gan To Kagaku Ryoho; 2007 May; 34(5):719-23. PubMed ID: 17496444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
    Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
    Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of oral squamous cell carcinoma responding to S-1].
    Harada K; Tamatani T; Bando T; Yoshida H
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
    Yamamoto K; Obara S; Mishima K; Nakamura H; Yoshimura Y
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):635-7. PubMed ID: 15114716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
    Harada K; Kawashima Y; Uchida D; Yoshida H
    Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma.
    Harada K; Sato M; Ueyama Y; Nagayama M; Hamakawa H; Nagahata S; Yoshimura Y; Osaki T; Ryoke K;
    Anticancer Drugs; 2008 Jan; 19(1):85-90. PubMed ID: 18043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
    Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
    N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
    Nomura T; Murakami R; Toya R; Teshima K; Nakahara A; Hirai T; Hiraki A; Nakayama H; Yoshitake Y; Ota K; Obayashi T; Yamashita Y; Oya N; Shinohara M
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1347-52. PubMed ID: 19628343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
    Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
    Ikeda H; Takebe Y; Irie A; Mizoguchi Y; Yamada K; Shibahara K; Inokuchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):677-9. PubMed ID: 12795100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
    Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
    Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indication of alternate-day treatment with S-1 in patients with oral cancer].
    Negishi A; Ogawa M; Kosugi K; Takayama Y; Gomi A; Miyazaki H; Yokoo S
    Gan To Kagaku Ryoho; 2015 May; 42(5):569-73. PubMed ID: 25981649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
    Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
    Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
    Koga M; Anegawa E; Yoh J; Tsuyama H; Sakaino H; Iwamoto O; Koga C; Kusukawa J
    Br J Oral Maxillofac Surg; 2010 Mar; 48(2):88-93. PubMed ID: 19576666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
    Harada K; Ferdous T; Yoshida H
    Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late phase II study of S-1 in patients with advanced head and neck cancer].
    Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
    Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M;
    Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.